Indonesia operates under a mixed healthcare model where public facilities exist alongside private hospitals concentrated in major urban centers. The Ministry of Health oversees the national health system through the BPJS Kesehatan universal coverage program implemented in 2014. Jakarta hosts the largest concentration of internationally accredited hospitals including Siloam Hospitals Lippo Village which received JCI accreditation in 2013, followed by facilities in Surabaya and Bali. Outside Java and Bali, medical infrastructure diminishes substantially. Papua and Maluku provinces maintain few specialists and unreliable supply chains for prescription medications. The national doctor-to-population ratio stands at approximately 0.4 physicians per 1,000 people according to WHO data from 2020, well below the recommended threshold. Travelers requiring specialized care or managing chronic conditions should establish healthcare access within Jakarta, Surabaya, Denpasar, or Bandung where cardiology, orthopedics, and diagnostic imaging meet international standards. Remote areas including Kalimantan interior, Nusa Tenggara islands, and the Raja Ampat archipelago require medical evacuation to reach adequate facilities, with flight times exceeding six hours from Papua to Jakarta.
Indonesia mandates yellow fever vaccination certificates only for travelers arriving from countries with yellow fever transmission risk. The list maintained by the Directorate General of Disease Prevention and Control includes 47 African and South American nations. No other vaccinations carry legal entry requirements as of 2024. The Indonesian Ministry of Health recommends routine immunizations remain current including measles-mumps-rubella, diphtheria-tetanus-pertussis, varicella, and polio. Hepatitis A transmission occurs throughout Indonesia via contaminated food and water, with higher incidence in areas lacking modern sanitation infrastructure. The seroprevalence rate for hepatitis A antibodies exceeds 90 percent in Indonesian adults according to studies published in the Journal of Clinical Virology in 2019, indicating widespread past exposure. Hepatitis B prevalence remains endemic at approximately 7.1 percent of the population based on Ministry of Health surveillance data from 2018. Typhoid fever persists in Indonesia with an estimated incidence of 81 cases per 100,000 population annually according to research published in Clinical Infectious Diseases in 2015. The conjugate typhoid vaccine demonstrates greater efficacy than the older polysaccharide version. Japanese encephalitis circulates in rural agricultural areas particularly across Java, Bali, and Kalimantan where rice paddies and pig farming create vector breeding conditions. Documented cases cluster during the rainy season from November through March. The JE vaccine series requires two doses administered 28 days apart. Rabies remains endemic across the archipelago with approximately 100 human deaths recorded annually. Bali experienced a significant outbreak beginning in 2008 with dog populations carrying the virus. The pre-exposure rabies vaccine series involves three injections over 21 to 28 days.
Malaria transmission occurs across most of Indonesia excluding Jakarta, major urban areas, and the tourist zones of Bali and Yogyakarta. Papua and West Papua provinces maintain the highest transmission intensity with Plasmodium falciparum and Plasmodium vivax both circulating. The Annual Parasite Incidence in Papua reached 23.2 per 1,000 population in 2019 according to Ministry of Health reports. Eastern Nusa Tenggara including Lombok and islands extending toward Timor also sustains year-round transmission. Maluku and North Maluku provinces report consistent cases particularly in coastal villages. Kalimantan shows focal transmission in forested interior regions. Sumatra exhibits lower but persistent transmission in Lampung, South Sumatra, and Aceh provinces. The Indonesian Ministry of Health and WHO recommend chemoprophylaxis for travelers to endemic areas. Atovaquone-proguanil, doxycycline, and mefloquine represent the primary options, each with distinct contraindications and side effect profiles requiring physician consultation. Chloroquine resistance appears widespread across Indonesian P. falciparum strains based on molecular surveillance published in Malaria Journal in 2018. Primaquine therapy for P. vivax requires G6PD testing to avoid hemolytic complications. Jakarta, Surabaya, Bandung, Semarang, Yogyakarta, Denpasar, and other cities above 1,000 meters elevation show negligible malaria risk. Travelers spending time exclusively in urban centers and established resort areas generally do not require chemoprophylaxis.
Dengue fever transmission occurs year-round throughout Indonesia with seasonal peaks during the rainy months from November to March. The Ministry of Health recorded 138,127 dengue cases in 2019 with case fatality rates around 0.9 percent. Jakarta, West Java, East Java, and Central Java provinces consistently report the highest absolute case numbers. All four dengue virus serotypes circulate simultaneously, creating risk for dengue hemorrhagic fever in individuals experiencing secondary infections with different serotypes. No vaccine currently holds approval for travelers in most countries, though the Dengvaxia vaccine received conditional licensing in Indonesia in 2016 for individuals aged 9 to 16 with prior documented dengue infection. Vector control focuses on eliminating standing water where Aedes aegypti mosquitoes breed. These mosquitoes bite primarily during daylight hours with peak activity two hours after sunrise and several hours before sunset. Chikungunya virus circulates in similar patterns transmitted by the same Aedes vectors, with 3,000 to 5,000 cases reported annually. Zika virus presence was confirmed in Indonesia in 2015 though surveillance remains limited and actual incidence unclear. Pregnant travelers face particular considerations given Zika's association with microcephaly.
Japanese encephalitis deserves separate consideration beyond vaccination status. The virus circulates in rural agricultural settings across Java, Bali, Kalimantan, and Sulawesi particularly near rice cultivation and pig farms. Human cases remain relatively rare with approximately 1,000 reported annually according to data compiled by the Japanese Encephalitis Surveillance Network, but underreporting affects these figures. The case fatality rate reaches 20 to 30 percent among symptomatic infections with neurological sequelae common in survivors. Culex mosquitoes transmit the virus primarily during evening and nighttime hours. Risk increases for travelers spending extended periods in rural villages, camping, or engaging in outdoor activities during dusk and dawn in agricultural regions. The vaccine provides protection exceeding 90 percent efficacy after the two-dose series.
Typhoid and paratyphoid fevers spread through contaminated food and water across Indonesia. The typhoid incidence study published in Clinical Infectious Diseases estimated 81 cases per 100,000 population with higher rates in children and young adults. Salmonella typhi bacteria causing typhoid shows increasing antibiotic resistance. Fluoroquinolone resistance exceeds 70 percent in isolates tested in Indonesian hospitals according to research in Antimicrobial Agents and Chemotherapy from 2017. The conjugate vaccine introduced in 2018 demonstrates improved immunogenicity compared to older formulations and provides protection lasting at least three years. Paratyphoid fever caused by Salmonella paratyphi A accounts for approximately 25 percent of enteric fever cases but no vaccine exists.
Hepatitis E transmission occurs sporadically through contaminated water supplies particularly during flooding and in areas with inadequate sanitation. Outbreaks have been documented in Jakarta and Central Java. The virus typically causes self-limited illness except in pregnant women where mortality can reach 20 percent. No vaccine is commercially available outside China. Cholera occurs periodically in Indonesia with outbreaks following natural disasters and floods. The Ministry of Health reported 178 cholera cases in 2018 with cases concentrated in Aceh, Papua, and Java. The oral cholera vaccine provides 65 percent protection for two years but vaccination is not routinely recommended for typical travelers.
Tuberculosis remains highly endemic in Indonesia with an estimated incidence of 319 cases per 100,000 population in 2020 according to WHO Global Tuberculosis Report. Indonesia ranks third globally in absolute TB burden after India and China. Drug-resistant TB including multidrug-resistant and extensively drug-resistant strains comprises approximately 2.4 percent of new cases and 13 percent of previously treated cases. Transmission occurs through prolonged indoor contact with infected individuals. Travelers planning extended stays particularly those working in healthcare, prisons, or refugee settings should consider baseline tuberculin skin testing or interferon-gamma release assays with repeat testing after return.
HIV prevalence in Indonesia reaches 0.4 percent in the general adult population based on UNAIDS estimates from 2020, but concentrated epidemics exist in key populations. Papua province shows the highest prevalence at 2.3 percent. Prevention relies on standard precautions regarding sexual contact and blood exposure. Post-exposure prophylaxis is available at select hospitals in major cities but medication availability varies.
Avian influenza H5N1 sporadic human cases occur in Indonesia particularly in West Java, Banten, and Jakarta provinces where backyard poultry farming remains common. Indonesia reported 200 confirmed human cases with 168 deaths between 2005 and 2021 according to WHO data, representing the highest national death toll globally. Transmission occurs through direct contact with infected birds or contaminated environments. Markets selling live poultry present elevated risk. No sustained human-to-human transmission has been documented.
Rabies vaccination decisions depend on planned activities and locations. The virus circulates in dog populations particularly in Bali following the 2008 introduction, plus Kalimantan, Sulawesi, Maluku, Nusa Tenggara, and Sumatra. Java and Papua remain officially rabies-free though smuggling of animals creates ongoing risk. Approximately 100 human rabies deaths occur annually with case fatality rates approaching 100 percent once symptoms develop. Dog bites account for most exposures though bats, monkeys, and other mammals can transmit. The pre-exposure vaccine series involves three injections but does not eliminate need for post-exposure treatment. Pre-exposure vaccination reduces the number of required post-exposure doses from four to two and eliminates need for rabies immunoglobulin which has limited availability outside Jakarta and Bali. Travelers planning extended rural stays, cycling, running, or activities increasing animal contact should strongly consider pre-exposure vaccination. Post-exposure rabies immunoglobulin is available at Dharmais Cancer Hospital Jakarta, Sanglah Hospital Denpasar, and select provincial hospitals but supply interruptions occur.
Leptospirosis transmission increases during rainy seasons through contact with water contaminated by rodent urine. Rice farmers, adventure travelers engaging in freshwater activities, and flood victims face elevated risk. The disease causes fever, jaundice, kidney failure, and bleeding with case fatality rates around 5 to 10 percent in severe cases. Outbreaks followed flooding in Jakarta in 2013 and 2020. Doxycycline prophylaxis shows some efficacy but is not routinely recommended. No vaccine is available.
Schistosomiasis caused by Schistosoma japonicum exists in limited foci in Central Sulawesi particularly around Lake Lindu and the Napu Valley. The Indonesian Ministry of Health conducts surveillance and control programs in endemic areas. The parasite transmits through freshwater snails when people contact contaminated water in lakes, rivers, or irrigation channels. Travelers to these specific areas should avoid freshwater contact. Most of Indonesia including all of Java, Bali, Sumatra, and Kalimantan remains free of schistosomiasis.
Melioidosis caused by Burkholderia pseudomallei bacteria exists in soil and water across Indonesia. The organism is endemic in Southeast Asia and northern Australia. Infection occurs through skin wounds, inhalation, or ingestion with symptoms ranging from localized skin infections to severe pneumonia and sepsis. Diabetes and chronic kidney disease increase susceptibility. No vaccine exists and treatment requires prolonged antibiotic courses. Data on Indonesian incidence remains limited but cases have been documented in Java, Kalimantan, and Papua.
Strongyloidiasis, a parasitic roundworm infection, shows high prevalence in rural Indonesian populations particularly in areas with soil contact and poor sanitation. Studies in East Java found prevalence rates of 20 to 30 percent in some villages. The parasite can persist for decades and cause severe disseminated disease if immunosuppression occurs. Travelers with prolonged barefoot soil contact face risk. Screening involves serology or stool examination.
Altitude illness affects travelers ascending Puncak Jaya (4,884 meters), Mount Kerinci (3,805 meters), Mount Semeru (3,676 meters), and Mount Rinjani (3,726 meters). Acute mountain sickness symptoms include headache, nausea, fatigue, and dizziness typically appearing 6 to 12 hours after rapid ascent above 2,500 meters. Acclimatization schedules should limit elevation gain to 300 to 500 meters per day above 3,000 meters. Acetazolamide prophylaxis at 125 milligrams twice daily starting one day before ascent reduces incidence. High-altitude pulmonary edema and high-altitude cerebral edema represent life-threatening complications requiring immediate descent. Supplemental oxygen availability varies by mountain and operator. Puncak Jaya expeditions involve technical climbing requiring proper equipment and experience.
Heat-related illness occurs frequently given Indonesia's tropical climate. Temperatures across the lowlands average 26 to 28 degrees Celsius year-round with high humidity often exceeding 80 percent. Heat exhaustion and heat stroke develop when physical exertion exceeds acclimatization capacity. Older adults, individuals taking anticholinergic medications, and those with cardiovascular disease face elevated risk. Acclimatization requires 10 to 14 days of progressive activity. Fluid requirements often reach 3 to 4 liters daily during outdoor activities. Electrolyte replacement becomes important during prolonged sweating. Heat stroke represents a medical emergency requiring rapid cooling.
Water and food safety precautions prevent the majority of traveler's diarrhea episodes. Municipal water systems in Jakarta, Surabaya, and other major cities undergo treatment but distribution systems may introduce contamination. Bottled water is widely available throughout Indonesia with major brands including Aqua, Club, and Ades. Travelers should verify bottle seals remain intact. Ice in urban restaurants typically comes from commercial suppliers using treated water but village ice may derive from untreated sources. Street food safety varies with freshly cooked hot items generally safer than items held at room temperature. Raw vegetables and fruits require washing in treated water or peeling. Unpasteurized dairy products carry risk of tuberculosis and brucellosis. Shellfish and raw fish dishes like sashimi present hepatitis A and parasitic risks particularly in areas with sewage contamination of coastal waters.
Traveler's diarrhea affects 30 to 50 percent of visitors to Indonesia typically within the first two weeks. Enterotoxigenic E. coli represents the most common bacterial cause followed by Campylobacter, Shigella, and Salmonella species. Viral gastroenteritis particularly norovirus also contributes. Parasitic causes including Giardia and Cryptosporidium occur less frequently but cause persistent symptoms. Most episodes resolve within 3 to 5 days with fluid replacement. Oral rehydration solutions containing sodium and glucose enhance fluid absorption. Loperamide provides symptomatic relief for mild to moderate diarrhea without high fever or bloody stools. Antibiotic treatment with azithromycin or fluoroquinolones shortens duration when bacterial causes are suspected. Travelers should carry a physician-prescribed antibiotic for self-treatment of moderate to severe symptoms. Persistent diarrhea lasting beyond 10 to 14 days requires medical evaluation and stool testing.
Marine hazards in Indonesian waters include venomous fish, jellyfish, sea snakes, and crocodiles. Stonefish inhabit shallow reefs and are nearly invisible when lying on the bottom. Their dorsal spines contain potent venom causing extreme pain, tissue necrosis, and potentially cardiovascular collapse. Antivenom is available at some hospitals in Bali and Jakarta. Scorpionfish and lionfish also deliver painful venomous stings. Box jellyfish including Chironex species appear seasonally in coastal waters particularly from October to May. Stings cause immediate pain with potential cardiac and respiratory effects. Vinegar application inactivates unfired nematocysts. Sea snake bites occur rarely as these animals are generally non-aggressive but their venom contains neurotoxins causing paralysis. Sea snakes are common in waters around Maluku, Papua, and Sulawatesi. Saltwater crocodiles inhabit coastal areas, estuaries, and rivers across Kalimantan, Papua, Maluku, and parts of Sulawesi and Sumatra. These animals reach 6 meters length and attack humans particularly in brackish water and river mouths. Stingrays embedded in sand deliver defensive barbed tail strikes causing severe pain and tissue damage. Shuffling feet when wading alerts rays to human presence. Crown-of-thorns starfish possess venomous spines causing painful wounds prone to infection. Blue-ringed octopus venom contains tetrodotoxin causing paralysis and respiratory failure with no antivenom available. Sea urchins abundant on reefs cause puncture wounds with spines often breaking off in tissue requiring removal.